Health Care/Hospital

ZEISS Attends the CIIE for the Third Consecutive Time to Showcase Innovative Optical Technologies

SHANGHAI, Nov. 7, 2020 /PRNewswire/ -- The opening ceremony of the third China International Import Expo (CIIE) took place at the National Convention and Exhibition Center (Shanghai) on November 4, demonstrating China's open and inclusive attitude to the world. This is the third consecutive time ...

2020-11-07 20:45 2930

CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients

TAIPEI and SAN DIEGO, Nov. 6, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced its clinical partner- Center for Advanced Research an...

2020-11-06 22:00 3311

Daewoong Pharmaceutical Announces Publication of Novel P-CAB Fexuprazan Phase 1 Bridging Study

SEOUL, South Korea, Nov. 6, 2020 /PRNewswire/ -- On October 27, the bridging study results on Fexuprazan, developed by the Korean pharmaceutical company, Daewoong Pharmaceutical (Daewoong; CEOSengho Jeon), was published in the SCI medical journal Alimentary Pharmacology and Therapeutics (AP&T). F...

2020-11-06 22:00 2414

Jeju Forum opens to discuss multilateral cooperation on pandemic, security

JEJU, South Korea, Nov. 6, 2020 /PRNewswire/ -- Organized by Jeju Peace Institute, an annual international peace forum opened on the southern resort island of Jeju on Thursday, with a focus on ways to shore up multilateral cooperation in tackling the coronavirus pandemic and promoting regional s...

2020-11-06 17:53 2814

Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China

SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners inChina at the third China International Import Expo (CIIE) inShanghai. These latest collaborations, faci...

2020-11-06 16:52 5626

Prebona proves unique, long-term effect against COVID-19/SARS CoV-2

STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Independent test-institutes have confirmed that Prebona Disinfect is extremely effective against the coronavirus - SARS CoV-2, COVID-19. The tests, conducted on textiles, shows that before and even after 10 machine washes, Prebona Disinfect still eliminates...

2020-11-06 16:15 1715

New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement

Key Highlights: * Specialised Therapeutics Asia (STA) to make QINLOCK® (ripretinib) available to appropriate patients inAustralia, New Zealand, Singapore, Malaysia and Brunei following exclusive distribution agreement * QINLOCK is already approved by the Therapeutics Good Administration (TGA)...

2020-11-06 05:30 2806

Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy

BAGSVÆRD, Denmark, Nov. 6, 2020 /PRNewswire/ -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP ...

2020-11-06 01:50 2321

PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period

NEW YORK, Nov. 5, 2020 /PRNewswire/ -- PolyActiva Pty Ltd, a clinical-stage Australian ophthalmology biopharmaceutical company, today announced it has successfully completed its Phase I clinical study for its lead candidate, the Latanoprost FA SR Ocular Implant. The device was well tolerated in ...

2020-11-05 21:00 889

Bactiguard maintains clear growth strategy and updates financial targets

STOCKHOLM, Nov. 5, 2020 /PRNewswire/ -- Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020. Bactiguard's growth strategy for the coming five-year period up to 2025 is based on a continued roll-out of Bactiguard's...

2020-11-05 17:52 6353

MEBO International Attended CIIE for the Third Time

SHANGHAI, Nov. 5, 2020 /PRNewswire/ -- On November 5, 2020, the third CIIE was grandly opened inShanghai. With the theme of "Regenerative World, Healthy Future," MEBO International attended the event again. This year marks the third CIIE and MEBO International has been in the event for three cons...

2020-11-05 17:44 2961

Porton Biologics Launched Gene and Cell Therapy CDMO Platform to Rank Among the Top of Pharma Solutions Platforms

SUZHOU, China, Nov. 5, 2020 /PRNewswire/ -- On November 1, the Opening Ceremony of Porton Biologics Gene and Cell Therapy CDMO Platform was held in Suzhou,China . As Porton Biologics is committed to building an end-to-end gene and cell therapy CDMO service platform, the phase I construction of th...

2020-11-05 15:35 4806

TCM Lianhua Qingwen's Access to Russian Market Marks Its Global Expansion

SHIJIAZHUANG, China, Nov. 5, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) discloses that it has received the Certificate of Registration for Dietary Supplements approved and issued by the authorized agency of Eurasian Economic Union, which indicates that the company's patent drug Lianhu...

2020-11-05 14:08 7620

Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC)

SHANGHAI, Nov. 5, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, recently announced that the Center for Drug Evaluation (CDE) ...

2020-11-05 13:59 1202

Retailers Need to Adjust to New Consumer Behaviors Shaped by COVID-19, according to Emerson Survey

HONG KONG, Nov. 5, 2020 /PRNewswire/ -- A survey released by Emerson's Commercial & Residential Solutions business shows that consumers have dramatically altered their shopping habits in response to COVID-19, putting pressure on retailers to adapt to changing consumption patterns. More than 8 ou...

2020-11-05 13:19 5201

Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020

SUZHOU and SHANGHAI, China, Nov. 4, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced two oral presentations at the...

2020-11-05 11:52 1160

CNN's 'Vital Signs' explores the healing powers of venom-derived medicine

HONG KONG, Nov. 5, 2020 /PRNewswire/ -- This month on CNN's 'Vital Signs', Chief Medical Correspondent Dr. Sanjay Gupta  explores the world of snake venom and toxin-derived medicine, and learns how some of nature's deadliest creatures are he...

2020-11-05 10:58 2959

Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform

HYDERABAD, India and CAMBRIDGE, Mass., Nov. 5, 2020 /PRNewswire/ -- Excelra , a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level o...

2020-11-05 10:00 2820

Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020

SAN FRANCISCO and SUZHOU, China, Nov. 5, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major disease...

2020-11-05 08:00 5623

U.S. FDA Accepts Ortho's Emergency Use Notification for VITROS(R) SARS-CoV-2 Antigen Test--Capable of Accurate Mass-Scale Testing

- Offered with 100 percent sensitivity[i] with samples with a PCR Cycle Threshold (CT) of  less than 34, Ortho's test may be better able to identify individuals with COVID-19 who are infectious compared to PCR - Ortho's new SARS-CoV-2 antigen test is the latest addition to the company's COVID-19...

2020-11-05 07:23 1310
1 ... 601602603604605606607 ... 807